FDA Approved: MELOXICAM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Meloxicam filed by Zydus Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• MELOXICAM (MELOXICAM)

Snippet

SUPPL AP for MELOXICAM (MELOXICAM)